We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > EBV

News List

Scientists Discover How the 'Mono' Virus Might Trigger MS drugs.com
January 26, 2022
A one-two punch from science has clearly tagged the mononucleosis virus, Epstein-Barr, as a major cause of multiple sclerosis.
HKBU-led Research Team Develops Anti-viral Targeted Drug for Nasopharyngeal Cancer Treatment americanpharmaceuticalreview
May 18, 2020
A research team led by Hong Kong, S.A.R., China Baptist University (HKBU) has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein produced by EBV, leading to the shrinkage of tumors caused by the virus.
Viracta Receives Orphan Drug Designation for Nanatinostat for EBV-Associated Cancers americanpharmaceuticalreview
April 17, 2019
Viracta Receives Orphan Drug Designation for Nanatinostat for EBV-Associated Cancers
Huakang Biomed Holdings announces its share offering biospectrumasia
December 03, 2018
The Group offers mainly three categories of IVD reagents, namely, male fertility IVD reagent, parasite antibody detection reagent and EBV antibody detection reagent